NANBV diagnostics and vaccines
    23.
    发明授权
    NANBV diagnostics and vaccines 失效
    NANBV诊断和疫苗

    公开(公告)号:US07790366B1

    公开(公告)日:2010-09-07

    申请号:US08441443

    申请日:1995-05-15

    IPC分类号: A61K39/00

    摘要: A family of cDNA sequences derived from hepatitis C virus (HCV) are provided. These sequences encode antigens which react immunologically with antibodies present in individuals with non-A non-B hepatitis (NANBH), but which are absent from individuals infected with hepatitis A virus, or hepatitis B virus, and also are absent in control individuals. The HCV cDNA sequences lack substantial homology to the sequences of hepatitis delta virus (HDV) and HBV. A comparison of the sequences of amino acids encoded in the HCV cDNA with the sequences of Flaviviruses indicates that HCV may be related to the Flaviviruses.The HCV cDNA sequences and the polypeptides encoded therein are useful as reagents for the detection and therapy of HCV. The reagents provided in the invention are also useful for the isolation of NANBH agent(s), for the propagation of these agents in tissue culture, and for the screening of antiviral agents for HCV.

    摘要翻译: 提供了源自丙型肝炎病毒(HCV)的cDNA序列家族。 这些序列编码与存在于非A非乙型肝炎(NANBH)的个体中存在的抗体进行免疫反应但是在感染甲型肝炎病毒或乙型肝炎病毒的个体中不存在的抗原,并且在对照个体中也不存在。 HCV cDNA序列与乙型肝炎病毒(HDV)和HBV的序列缺乏实质同源性。 HCV cDNA编码的氨基酸序列与黄病毒序列的比较表明,HCV可能与黄病毒有关。 HCV cDNA序列及其中编码的多肽可用作检测和治疗HCV的试剂。 本发明中提供的试剂也可用于分离NANBH剂,用于组织培养中这些试剂的繁殖,以及筛选用于HCV的抗病毒剂。

    Antibody compositions to HCV and uses thereof
    24.
    发明授权
    Antibody compositions to HCV and uses thereof 失效
    HCV抗体组合物及其用途

    公开(公告)号:US06171782B2

    公开(公告)日:2001-01-09

    申请号:US08442647

    申请日:1995-05-15

    IPC分类号: C12Q170

    摘要: A family of cDNA sequences derived from hepatitis C virus (HCV) are provided. These sequences encode antigens which react immunologically with antibodies present in individuals with non-A non-B hepatitis (NANBH), but which are absent from individuals infected with hepatitis A virus, or hepatitis B virus, and also are absent in control individuals. The HCV cDNA sequences lack substantial homology to the sequences of hepatitis delta virus (HDV) and HBV. A comparison of the sequences of amino acids encoded in the HCV cDNA with the sequences of Flaviviruses indicates that HCV may be related to the Flaviviruses. The HCV cDNA sequences and the polypeptides encoded therein are useful as reagents for the detection and therapy of HCV. The reagents provided in the invention are also useful for the isolation of NANBH agent(s), for the propagation of these agents in tissue culture, and for the screening of antiviral agents for HCV.

    摘要翻译: 提供了源自丙型肝炎病毒(HCV)的cDNA序列家族。 这些序列编码与存在于非A非乙型肝炎(NANBH)的个体中存在的抗体进行免疫反应但是在感染甲型肝炎病毒或乙型肝炎病毒的个体中不存在的抗原,并且在对照个体中也不存在。 HCV cDNA序列与乙型肝炎病毒(HDV)和HBV的序列缺乏实质同源性。 HCV cDNA编码的氨基酸序列与黄病毒序列的比较表明,HCV可能与黄病毒有关。HCV cDNA序列及其中编码的多肽可用作检测和治疗HCV的试剂。 本发明中提供的试剂也可用于分离NANBH剂,用于组织培养中这些试剂的繁殖,以及筛选用于HCV的抗病毒剂。

    Immunoassays for anti-HCV antibodies employing combinations of hepatitis
C virus (HCV) antigens
    25.
    发明授权
    Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens 失效
    使用丙型肝炎病毒(HCV)抗原组合的抗HCV抗体的免疫测定

    公开(公告)号:US5712087A

    公开(公告)日:1998-01-27

    申请号:US440519

    申请日:1995-05-12

    IPC分类号: C07K14/18 G01N33/576 C12Q1/70

    摘要: Combinations of HCV antigens that have a broader range of immunological reactivity than any single HCV antigen. The combinations consist of an antigen from the C domain of the HCV polyprotein, and at least one additional HCV antigen from either the NS3 domain, the NS4 domain, the S domain, or the NS5 domain, and are in the form of a fusion protein, a simple physical mixture, or the individual antigens commonly bound to a solid matrix.

    摘要翻译: 具有比任何单一HCV抗原具有更广泛的免疫反应性的HCV抗原的组合。 该组合由HCV多蛋白C区的抗原和至少一种来自NS3结构域,NS4结构域,S结构域或NS5结构域的另外的HCV抗原组成,并且是融合蛋白的形式 ,简单的物理混合物,或通常与固体基质结合的单个抗原。

    Hepatitis C immunoassays
    26.
    发明授权
    Hepatitis C immunoassays 失效
    丙型肝炎免疫测定

    公开(公告)号:US5698390A

    公开(公告)日:1997-12-16

    申请号:US306472

    申请日:1994-09-15

    摘要: A family of cDNA sequences derived from hepatitis C virus (HCV) are provided. These sequences encode antigens which react immunologically with antibodies present in individuals with non-A non-B hepatitis (NANBH), but which are absent from individuals infected with hepatitis A virus, or hepatitis B virus, and also are absent in control individuals. The HCV cDNA sequences lack substantial homology to the sequences of hepatitis delta virus (HDV) and HBV. A comparison of the sequences of amino acids encoded in the HCV cDNA with the sequences of Flaviviruses indicates that HCV may be related to the Flaviviruses. The HCV cDNA sequences and the polypeptides encoded therein are useful as reagents for the detection and therapy of HCV. The reagents provided in the invention are also useful for the isolation of NANBH agent(s), for the propagation of these agents in tissue culture, and for the screening of antiviral agents for HCV.

    摘要翻译: 提供了源自丙型肝炎病毒(HCV)的cDNA序列家族。 这些序列编码与存在于非A非乙型肝炎(NANBH)的个体中存在的抗体进行免疫反应但是在感染甲型肝炎病毒或乙型肝炎病毒的个体中不存在的抗原,并且在对照个体中也不存在。 HCV cDNA序列与乙型肝炎病毒(HDV)和HBV的序列缺乏实质同源性。 HCV cDNA编码的氨基酸序列与黄病毒序列的比较表明,HCV可能与黄病毒有关。 HCV cDNA序列及其中编码的多肽可用作检测和治疗HCV的试剂。 本发明中提供的试剂也可用于分离NANBH剂,用于组织培养中这些试剂的繁殖,以及筛选用于HCV的抗病毒剂。